Journal of the Korean Academy of Child and Adolescent Psychiatry

Korean Academy of Child and Adolescent Psychiatry (대한소아청소년정신의학회)
권호 표지
DOI QR코드

DOI QR Code

Korean Clinical Guideline for Autism Spectrum Disorder - Clinical Features, Course, Epidemiology, and Cause

  • Jun-Won Hwang (Department of Psychiatry, Kangwon National University Hospital, Kangwon National University School of Medicine) ;
  • Jeong-Seop Lee (Department of Psychiatry, Inha University Hospital, Inha University School of Medicine)
  • Received : 2023.04.07
  • Accepted : 2023.12.03
  • Published : 2024.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Autism spectrum disorder (ASD) is a heterogeneous developmental disorder characterized by impairments in two core areas: 1) social communication and interaction and 2) restricted and repetitive patterns of behaviors and interests. In general, ASD is known to be a lifelong disorder. Follow-up studies from childhood to adulthood have reported that the severity of the key symptoms ASD decreases over time. However, chronic health problems including mental health occur in many patients with ASD. The prevalence of ASD has increased from around 0.04% in the 1970s to 2.8% at present. The average age of diagnosis in developed countries is 38-120 months of age. Recent evidence suggests that biological factors which include genetic, congenital, immunological, neuroanatomical, biochemical, and environmental ones are important in causing autism. Until now, early signs and various risk factors of ASD have been suggested.

Keywords

Acknowledgement

This study was supported by the Ministry of Health and Welfare, Behavior and Development Center, and the Headquarter of the National Autism and Developmental Disorder Centers.

References

  1. Korean Neuropsychiatric Association. Textbook of neuropsychiatry. 3rd ed. Seoul: iMiS Company;2017. p.185-188.
  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association;2013.
  3. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-250.
  4. Hong KE. Korean textbook of child psychiatry. 2nd ed. Seoul: Hakjisa;2014. p.145-166.
  5. World Health Organization. 6A02 autism spectrum disorder. International classification of diseases for mortality and morbidity statistics, 11th revision, v2020-09 [Internet]. Geneva: World Health Organization [cited 2023 Apr 6]. Available from: https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/437815624.
  6. Statistics Korea. Korean standard classification of diseases, 8th revision (KCD-8) [Internet]. Daejeon: Statistics Korea [cited 2023 Apr 6]. Available from: https://kostat.go.kr/board.es?mid=a10301010000&bid=246&tag=&act=view&list_no=383272&ref_bid=.
  7. Fein D, Barton M, Eigsti IM, Kelley E, Naigles L, Schultz RT, et al. Optimal outcome in individuals with a history of autism. J Child Psychol Psychiatry 2013;54:195-205.
  8. Pickles A, McCauley JB, Pepa LA, Huerta M, Lord C. The adult outcome of children referred for autism: typology and prediction from childhood. J Child Psychol Psychiatry 2020;61:760-767.
  9. Simonoff E, Kent R, Stringer D, Lord C, Briskman J, Lukito S, et al. Trajectories in symptoms of autism and cognitive ability in autism from childhood to adult life: findings from a longitudinal epidemiological cohort. J Am Acad Child Adolesc Psychiatry 2020;59:1342-1352.
  10. Howlin P, Magiati I. Autism spectrum disorder: outcomes in adulthood. Curr Opin Psychiatry 2017;30:69-76.
  11. Fuentes J, Hervas A, Howlin P; ESCAP ASD Working Party. ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment. Eur Child Adolesc Psychiatry 2021;30:961-984.
  12. Orinstein AJ, Suh J, Porter K, De Yoe KA, Tyson KE, Troyb E, et al. Social function and communication in optimal outcome children and adolescents with an autism history on structured test measures. J Autism Dev Disord 2015;45:2443-2463.
  13. Mason D, Ingham B, Urbanowicz A, Michael C, Birtles H, Woodbury-Smith M, et al. A systematic review of what barriers and facilitators prevent and enable physical healthcare services access for autistic adults. J Autism Dev Disord 2019;49:3387-3400.
  14. Smith DaWalt L, Hong J, Greenberg JS, Mailick MR. Mortality in individuals with autism spectrum disorder: predictors over a 20-year period. Autism 2019;23:1732-1739.
  15. Barnard-Brak L, Richman D, Yang Z. Age at death and comorbidity of dementia-related disorders among individuals with autism spectrum disorder. Adv Autism 2019;5:293-302.
  16. Fombonne E. Editorial: the rising prevalence of autism. J Child Psychol Psychiatry 2018;59:717-720.
  17. Centers for Disease Control and Prevention. Autism prevalence higher, according to data from 11 ADDM communities [Internet]. Atlanta, GA: Centers for Disease Control and Prevention [cited 2023 Aug 7]. Available from: https://www.cdc.gov/media/releases/2023/p0323-autism.html.
  18. Shaw KA, Williams S, Hughes MM, Warren Z, Bakian AV, Durkin MS, et al. Statewide county-level autism spectrum disorder prevalence estimates-seven U.S. states, 2018. Ann Epidemiol 2023;79:39-43.
  19. Sacco R, Camilleri N, Eberhardt J, Umla-Runge K, Newbury-Birch D. The prevalence of autism spectrum disorder in Europe. In: Carotenuto M, editor. Autism spectrum disorders - recent advances and new perspectives. London: InTech;2023.
  20. Kim YS, Fombonne E, Koh YJ, Kim SJ, Cheon KA, Leventhal BL. A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample. J Am Acad Child Adolesc Psychiatry 2014;53:500-508.
  21. World Health Organization. Autism [Internet]. Geneva: World Health Organization [cited 2023 Aug 7]. Available from: https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders.
  22. Fombonne E. Epidemiological studies of pervasive developmental disorders. In: Volkmar FR, Paul R, Klin A, Cohen D, editors. Handbook of autism and pervasive developmental disorders: diagnosis, development, neurobiology, and behavior. Hoboken, NJ: Wiley;2005. p.42-69.
  23. Richards M, Mossey J, Robins DL. Parents' concerns as they relate to their child's development and later diagnosis of autism spectrum disorder. J Dev Behav Pediatr 2016;37:532-540.
  24. Becerra-Culqui TA, Lynch FL, Owen-Smith AA, Spitzer J, Croen LA. Parental first concerns and timing of autism spectrum disorder diagnosis. J Autism Dev Disord 2018;48:3367-3376.
  25. Centers for Disease Control and Prevention. Autism spectrum disorder (ASD): signs and symptoms [Internet]. Atlanta, GA: Centers for Disease Control and Prevention [cited 2023 Apr 6]. Available from: http://medbox.iiab.me/modules/en-cdc/www.cdc.gov/ncbddd/autism/signs.html.
  26. Hyman SL, Levy SE, Myers SM. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics 2020;145:e20193447.
  27. Siu AL; US Preventive Services Task Force (USPSTF). Screening for autism spectrum disorder in young children: US preventive services task force recommendation statement. JAMA 2016;315:691-696.
  28. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: recognition, referral and diagnosis [Internet]. Manchester: National Institute for Health and Care Excellence [cited 2023 Apr 6]. Available from: https://www.nice.org.uk/guidance/cg128.
  29. DeLong GR, Dwyer JT. Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. J Autism Dev Disord 1988;18:593-600.
  30. Gillberg C, Gillberg IC, Steffenburg S. Siblings and parents of children with autism: a controlled population-based study. Dev Med Child Neurol 1992;34:389-398.
  31. Szatmari P, Jones MB, Tuff L, Bartolucci G, Fisman S, Mahoney W. Lack of cognitive impairment in first-degree relatives of children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1993;32:1264-1273.
  32. Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877-900.
  33. Jorde A, Knoll B. [Obstetric management and results of premature amniotic rupture]. Zentralbl Gynakol 1991;113:591-599. German
  34. Szatmari P, Jones MB, Fisman S, Tuff L, Bartolucci G, Mahoney WJ, et al. Parents and collateral relatives of children with pervasive developmental disorders: a family history study. Am J Med Genet 1995;60:282-289.
  35. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977;18:297-321.
  36. Ritvo ER, Spence MA, Freeman BJ, Mason-Brothers A, Mo A, Marazita ML. Evidence for autosomal recessive inheritance in 46 families with multiple incidences of autism. Am J Psychiatry 1985;142:187-192.
  37. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 1989;30:405-416.
  38. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
  39. Smalley SL. Genetic influences in autism. Psychiatr Clin North Am 1991;14:125-139.
  40. Alonso-Gonzalez A, Calaza M, Rodriguez-Fontenla C, Carracedo A. Novel gene-based analysis of ASD GWAS: insight into the biological role of associated genes. Front Genet 2019;10:733.
  41. Robinson EB, St Pourcain B, Anttila V, Kosmicki JA, Bulik-Sullivan B, Grove J, et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat Genet 2016;48:552-555.
  42. Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol Autism 2017;8:21.
  43. Tsai LY. Pre-, peri-, and neonatal factors in autism. In: Schopler E, Mesibov GB, editors. Neurobiological issues in autism. New York: Springer;1987. p.179-189.
  44. Maimburg RD, Vaeth M. Perinatal risk factors and infantile autism. Acta Psychiatr Scand 2006;114:257-264.
  45. Juul-Dam N, Townsend J, Courchesne E. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics 2001;107:E63.
  46. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004;61:618-627.
  47. Deykin EY, MacMahon B. The incidence of seizures among children with autistic symptoms. Am J Psychiatry 1979;136:1310-1312.
  48. Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord 1986;16:189-197.
  49. Weizman A, Weizman R, Szekely GA, Wijsenbeek H, Livni E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry 1982;139:1462-1465.
  50. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005;17:485-495.
  51. Kemper TL, Bauman ML. Neuropathology of infantile autism. Mol Psychiatry 2002;7(Suppl 2):S12-S13.
  52. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001;57:245-254.
  53. Sears LL, Vest C, Mohamed S, Bailey J, Ranson BJ, Piven J. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:613-624.
  54. Hardan AY, Minshew NJ, Keshavan MS. Corpus callosum size in autism. Neurology 2000;55:1033-1036.
  55. Baron-Cohen S, Ring HA, Wheelwright S, Bullmore ET, Brammer MJ, Simmons A, et al. Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci 1999;11:1891-1898.
  56. Castelli F, Frith C, Happe F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 2002;125(Pt 8):1839-1849.
  57. Narayan M, Srinath S, Anderson GM, Meundi DB. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993;33:630-635.
  58. Cohen DJ, Shaywitz BA, Johnson WT, Bowers M Jr. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 1974;31:845-853.
  59. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006;27:254-289.
  60. Mandy W, Lai MC. Towards sex- and gender-informed autism research. Autism 2017;21:643-645.
  61. Idring S, Magnusson C, Lundberg M, Ek M, Rai D, Svensson AC, et al. Parental age and the risk of autism spectrum disorders: findings from a Swedish population-based cohort. Int J Epidemiol 2014;43:107-115.
  62. Zerbo O, Yoshida C, Gunderson EP, Dorward K, Croen LA. Inter-pregnancy interval and risk of autism spectrum disorders. Pediatrics 2015;136:651-657.
  63. Lyall K, Ashwood P, Van de Water J, Hertz-Picciotto I. Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord 2014;44:1546-1555.
  64. Christensen J, Gronborg TK, Sorensen MJ, Schendel D, Parner ET, Pedersen LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696-1703.
  65. Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA 2017;317:1544-1552.
  66. Lampi KM, Lehtonen L, Tran PL, Suominen A, Lehti V, Banerjee PN, et al. Risk of autism spectrum disorders in low birth weight and small for gestational age infants. J Pediatr 2012;161:830-836.
  67. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (childhood autism risks from genetics and environment) case-control study. Am J Clin Nutr 2012;96:80-89.
  68. Zerbo O, Qian Y, Yoshida C, Fireman BH, Klein NP, Croen LA. Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatr 2017;171:e163609.